Oncology Drug Discovery Applications Using the FMAT™ 8100 HTS System
Open Access
- 1 January 2003
- journal article
- Published by Elsevier in SLAS Discovery
- Vol. 8 (1) , 81-88
- https://doi.org/10.1177/1087057102239668
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemiaJournal of Clinical Investigation, 2000
- The Hallmarks of CancerCell, 2000
- Homogeneous Cell- and Bead-Based Assays for High Throughput Screening Using Fluorometric Microvolume Assay TechnologySLAS Discovery, 1999
- CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASESAnnual Review of Cell and Developmental Biology, 1997
- LEUKOCYTE PROTEIN TYROSINE KINASES:Potential Targets for Drug DiscoveryAnnual Review of Immunology, 1997
- Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.The Journal of Experimental Medicine, 1995
- Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteinsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1994
- Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factorCell, 1993
- Mechanisms and Functions of Cell DeathAnnual Review of Cell Biology, 1991
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986